These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2337956)

  • 1. Synthesis and pharmacological properties of azido derivatives of 1,5-benzothiazepine Ca antagonist.
    Narita H; Gaino M; Suzuki T; Kurosawa H; Inoue H; Nagao T
    Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):407-10. PubMed ID: 2337956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of 1,5-benzothiazepine derivatives having a l-cis and d-cis configuration in anesthetized dogs.
    Kaburaki M; Inoue H; Doi H; Yasuhara M; Narita H
    Biol Pharm Bull; 1998 Jan; 21(1):50-5. PubMed ID: 9477168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profile of a novel 1,5-benzothiazepine calcium antagonist.
    Shiga H; Miyake S; Ideka M; Ito Y; Yanagisawa H; Koike H
    Arzneimittelforschung; 1992 May; 42(5):617-21. PubMed ID: 1530673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of SAS 1310, a new calcium antagonist, on isolated myocardial and smooth muscle preparations.
    Cargnelli G; Padrini R; Piovan D; Moretto R; Bova S
    Eur J Pharmacol; 1987 Apr; 136(2):163-70. PubMed ID: 3595719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-Type calcium channel blockers: from diltiazem to 1,2,4-oxadiazol-5-ones via thiazinooxadiazol-3-one derivatives.
    Budriesi R; Cosimelli B; Ioan P; Ugenti MP; Carosati E; Frosini M; Fusi F; Spisani R; Saponara S; Cruciani G; Novellino E; Spinelli D; Chiarini A
    J Med Chem; 2009 Apr; 52(8):2352-62. PubMed ID: 19323482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding characteristics of a new 1,5-benzothiazepine, clentiazem, to rat cerebral cortex and skeletal muscle membranes.
    Suzuki T; Kurosawa H; Naito K; Otsuka M; Ohashi M; Takaiti O
    Eur J Pharmacol; 1991 Mar; 194(2-3):195-200. PubMed ID: 2060600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel receptor binding studies for diltiazem and its major metabolites: functional correlation to inhibition of portal vein myogenic activity.
    Schoemaker H; Hicks PE; Langer SZ
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):173-80. PubMed ID: 2435995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular actions of TA 3090, a novel analog of diltiazem: interaction with endothelium-dependent relaxation in canine femoral and coronary arteries.
    Rubanyi G; Iqbal A; Schwartz A; Vanhoutte PM
    J Pharmacol Exp Ther; 1991 Nov; 259(2):639-42. PubMed ID: 1941612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrrolo[2,1-c][1,4]benzothiazines: synthesis, structure-activity relationships, molecular modeling studies, and cardiovascular activity.
    Campiani G; Garofalo A; Fiorini I; Botta M; Nacci V; Tafi A; Chiarini A; Budriesi R; Bruni G; Romeo MR
    J Med Chem; 1995 Oct; 38(22):4393-410. PubMed ID: 7473567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of a new 1,5-benzothiazepine calcium antagonist in anesthetized dogs.
    Murata S; Kikkawa K; Yabana H; Nagao T
    Arzneimittelforschung; 1988 Apr; 38(4):521-5. PubMed ID: 3401267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of halogen-substituted 1,5-benzothiazepine derivatives and their vasodilating and hypotensive activities.
    Inoue H; Konda M; Hashiyama T; Otsuka H; Takahashi K; Gaino M; Date T; Aoe K; Takeda M; Murata S
    J Med Chem; 1991 Feb; 34(2):675-87. PubMed ID: 1995892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel.
    Ivorra MD; Lugnier C; Schott C; Catret M; Noguera MA; Anselmi E; D'Ocon P
    Br J Pharmacol; 1992 Jun; 106(2):387-94. PubMed ID: 1327380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-affinity binding of [3H]DTZ323 to the diltiazem-binding site of L-type Ca2+ channels.
    Hagiwara M; Adachi-Akahane S; Nagao T
    Eur J Pharmacol; 2003 Apr; 466(1-2):63-71. PubMed ID: 12679142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of novel calcium channel blockers: 2,5-dihydro-4-methyl-2-phenyl-1,5-benzothiazepine-3-carboxylic acid esters and 2,5-dihydro-4-methyl-2-phenyl-1,5-benzodiazepine-3-carboxylic acid esters.
    Atwal KS; Bergey JL; Hedberg A; Moreland S
    J Med Chem; 1987 Apr; 30(4):635-40. PubMed ID: 2435903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive inotropic and negative chronotropic effects of (-)-cis-diltiazem in rat isolated atria.
    Nasa Y; Ichihara K; Yoshida R; Abiko Y
    Br J Pharmacol; 1992 Mar; 105(3):696-702. PubMed ID: 1378343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of vascular relaxation by thaligrisine: functional and binding assays.
    Tur R; Magraner J; Catret M; Elorriaga M; Ivorra MD; D'Ocon P; Bermejo A; Cabedo N; Cortes D; Anselmi E
    Life Sci; 2000 Aug; 67(13):1535-48. PubMed ID: 10983849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
    Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
    Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.